Yanbing Ma
- Microbiology top 1%
- Bacterial Infections and Vaccines 7
- Antimicrobial Peptides and Activities 4
- Molecular Medicine top 5%
- Cancer Research top 5%
- Endocrinology top 5%
- Immunology top 10%
- Immunotherapy and Immune Responses 13
-
- Bacteriophages and microbial interactions 7
-
- RNA Interference and Gene Delivery 6
- vaccines and immunoinformatics approaches 5
-
- Cancer Research and Treatments 5
-
- Pneumonia and Respiratory Infections 4
Yanbing Ma
45 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 103
- Microbiology 430
- Molecular Medicine 144
- Cancer Research 363
- Endocrinology 102
- Immunology 416
Countries citing papers authored by Yanbing Ma
This map shows the geographic impact of Yanbing Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanbing Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanbing Ma more than expected).
Fields of papers citing papers by Yanbing Ma
This network shows the impact of papers produced by Yanbing Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanbing Ma. The network helps show where Yanbing Ma may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yanbing Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 32 | |
| 3 | 2023 | 21 | |
| 4 | 2023 | 9 | |
| 5 | 2022 | 79 | |
| 6 | 2022 | 4 | |
| 7 | 2021 | 30 | |
| 8 | 2020 | 11 | |
| 9 | 2018 | 32 | |
| 10 | 2018 | 32 | |
| 11 | 2017 | 313 | |
| 12 | 2017 | 13 | |
| 13 | 2015 | 17 | |
| 14 | 2014 | 5 | |
| 15 | 2013 | 31 | |
| 16 | 2009 | 44 | |
| 17 | 2008 | 11 | |
| 18 | 2007 | 40 | |
| 19 | The Gene Cloning, Expression in E.coli and Purification of Human Keratinocyte Growth Factor-2 and Its Bioactivity Assay | 2001 | 2 |
| 20 | 1997 | 32 |
About Yanbing Ma
Yanbing Ma is a scholar working on Microbiology, Immunology and Biotechnology, having authored 47 papers that have together received 1.7k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (13 papers), Bacterial Infections and Vaccines (7 papers), Bacteriophages and microbial interactions (7 papers), RNA Interference and Gene Delivery (6 papers), vaccines and immunoinformatics approaches (5 papers), Cancer Research and Treatments (5 papers), Antimicrobial Peptides and Activities (4 papers) and Pneumonia and Respiratory Infections (4 papers). The work is most often cited by research in Microbiology (430 citations), Molecular Medicine (144 citations) and Cancer Research (363 citations). Yanbing Ma has collaborated with scholars based in China, Canada and France. Frequent co-authors include Weiwei Huang, Cunbao Liu, Wenjia Sun, Liangqun Hua, Hongmei Bai, Qishu Zhang, Xu Yang, Qiong Long, Weiran Li and Yang Gao. Their work appears in journals such as International Journal of Nanomedicine, Journal of Nanobiotechnology, Scientific Reports, Frontiers in Immunology and ACS Applied Materials & Interfaces.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.